Childhood liposarcoma: a single-institutional twenty-year experience. 1999

A Ferrari, and M Casanova, and F Spreafico, and R Luksch, and M Terenziani, and G Cefalo, and M Massimino, and L Gandola, and P Navarria, and F Fossati-Bellani
Division of Pediatric Oncology, Istituto Nazionale Tumori, Milano, Italy. ferrari@istitutotumori.mi.it

A retrospective observational study was performed on a series of 12 consecutive pediatric patients treated over a 20-year period at the Istituto Nazionale Tumori, Milano. Conservative surgery was the treatment of choice in all patients; radical excision was obtained at diagnosis in 9 cases and after primary chemotherapy in 1 case. Five patients were subjected to surgery alone, and one to postoperative radiotherapy. After a median follow-up of 11 years (range 1-20), all the patients were alive without evidence of disease, 11 in first complete remission, and 1 after local relapse. In agreement with other reports, the authors underline the unquestionable pivotal role of radical surgery in the treatment of liposarcoma. The high proportion of resectable tumors accounts for the excellent survival of the patients in this study. The role of both adjuvant chemotherapy and radiotherapy is uncertain and awaits multicentric cooperative prospective studies.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008080 Liposarcoma A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed) Liposarcoma, Dedifferentiated,Liposarcoma, Pleomorphic,Atypical Lipomatous Tumor,Liposarcoma, Well Differentiated,Well Differentiated Liposarcoma,Atypical Lipomatous Tumors,Dedifferentiated Liposarcoma,Dedifferentiated Liposarcomas,Lipomatous Tumor, Atypical,Liposarcomas,Pleomorphic Liposarcoma,Pleomorphic Liposarcomas,Well Differentiated Liposarcomas
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

A Ferrari, and M Casanova, and F Spreafico, and R Luksch, and M Terenziani, and G Cefalo, and M Massimino, and L Gandola, and P Navarria, and F Fossati-Bellani
January 1970, Medical times,
A Ferrari, and M Casanova, and F Spreafico, and R Luksch, and M Terenziani, and G Cefalo, and M Massimino, and L Gandola, and P Navarria, and F Fossati-Bellani
July 2007, Cancer,
A Ferrari, and M Casanova, and F Spreafico, and R Luksch, and M Terenziani, and G Cefalo, and M Massimino, and L Gandola, and P Navarria, and F Fossati-Bellani
January 2020, Advanced biomedical research,
A Ferrari, and M Casanova, and F Spreafico, and R Luksch, and M Terenziani, and G Cefalo, and M Massimino, and L Gandola, and P Navarria, and F Fossati-Bellani
January 2009, Clinical medicine. Pediatrics,
A Ferrari, and M Casanova, and F Spreafico, and R Luksch, and M Terenziani, and G Cefalo, and M Massimino, and L Gandola, and P Navarria, and F Fossati-Bellani
January 1985, International orthopaedics,
A Ferrari, and M Casanova, and F Spreafico, and R Luksch, and M Terenziani, and G Cefalo, and M Massimino, and L Gandola, and P Navarria, and F Fossati-Bellani
November 2008, Gynecologic oncology,
A Ferrari, and M Casanova, and F Spreafico, and R Luksch, and M Terenziani, and G Cefalo, and M Massimino, and L Gandola, and P Navarria, and F Fossati-Bellani
May 2013, Journal of paediatrics and child health,
A Ferrari, and M Casanova, and F Spreafico, and R Luksch, and M Terenziani, and G Cefalo, and M Massimino, and L Gandola, and P Navarria, and F Fossati-Bellani
January 2016, Journal of neuro-oncology,
A Ferrari, and M Casanova, and F Spreafico, and R Luksch, and M Terenziani, and G Cefalo, and M Massimino, and L Gandola, and P Navarria, and F Fossati-Bellani
January 2018, Blood,
A Ferrari, and M Casanova, and F Spreafico, and R Luksch, and M Terenziani, and G Cefalo, and M Massimino, and L Gandola, and P Navarria, and F Fossati-Bellani
January 2024, Diagnostic cytopathology,
Copied contents to your clipboard!